Stimulation of a cell with insulin initiates a signal transduction cascade that results in cellular activities that include phosphorylation of the receptor itself. Measurement of the degree of phosphorylation can serve as a marker for receptor activation. Receptor phosphorylation has been measured using Western blot analysis, which is very low throughput and not easily quantifiable. The goal of this project was to develop a cell-based assay to measure receptor phosphorylation in high throughput. This report describes a cell-based assay for insulin receptor phosphorylation that is robust and amenable to high-volume screening in a microwell format. (Journal of Biomolecular Screening 2003:439-446) 
INTRODUCTION
I nsulin has numerous anabolic effects, including the regulation of carbohydrate, protein, and lipid metabolism. The pleitropic effects of insulin are mediated upon hormone binding to the cellsurface insulin receptor. The insulin receptor is a heterotetrameric tyrosine kinase composed of 2 alpha subunits and 2 beta subunits. 1 Insulin binding to the extracellular alpha subunit initiates receptor dimerization, activation of the intrinsic tyrosine kinase activity of the beta subunit, and transphosphorylation of the receptor on several tyrosine residues (Y1146, Y1150, Y1151, Y1316, and Y1322). 2 The activated insulin receptor kinase subsequently phosphorylates numerous intracellular substrates, including the insulin receptor substrate (IRS)-1, IRS-2, and Shc. 3, 4 Specific phosphotyrosine residues provide binding sites for several adaptor proteins, thus setting the stage for the transmission of the insulin signal to the appropriate downstream effectors.
Activation of the insulin receptor can be measured by quantifying the extent of insulin receptor phosphorylation either directly or indirectly. One method to measure receptor phosphorylation directly is by immunoprecipitation. 5 This is typically accomplished by stimulating the cells with ligand and then lysing the cells, fol-lowed by immunoprecipitation of the receptor of interest. The precipitate is subsequently electrophoresed through a gel and interrogated with labeled antibody to the phosphorylated tyrosine residue. This method is labor intensive, difficult to quantify, and slow in terms of throughput.
A few indirect methods have been developed to measure phosphorylation induced by insulin. One method takes advantage of the fact that the intrinsic tyrosine kinase activity of the receptor is increased following autophosphorylation of the receptor (Fig.  1 ). 6 In this method, the cells are stimulated and lysed using a buffer that preserves the phosphorylation state of the insulin receptor. The receptor is captured onto a plate coated with receptor antibody by incubating the lysate with the plate overnight at 4°C. The receptorcontaining well is washed, leaving the intact beta subunit of the receptor kinase behind. The immobilized receptor is then used as the enzyme source, and the ability of the receptor to phosphorylate a substrate in solution is determined. We chose to use a homogeneous system with a substrate that, when phosphorylated, was able to fluoresce at an appropriate wavelength. We also chose to use a biotinylated IRS sequence containing a phosphorylation site as a substrate. The degree of phosphorylation was measured using a fluorescence resonance energy transfer (FRET) assay that used XL-665 streptavidin to bind biotin and a europium-tagged antiphosphotyrosine antibody. With this detection method, all substrate is bound by the XL-665, whereas only the phosphorylated substrate is bound by the europium-tagged antibody, thus allowing energy transfer between the europium and the XL-665. Although this method had a higher throughput and produced EC 50 values for insulin that paralleled those determined by others, this method still relies on the measurement of mimetic action via an indirect means.
Recently, a cell-based assay was reported to measure receptor phosphorylation of trkA directly from cell lysates in a 96-well format. 7 In this method, cells in 96-well plates were stimulated, lysed, sonicated, and centrifuged, all within the 96-well plate. The clarified lysate was then transferred to a 96-well plate coated with an antibody directed against the receptor. The plate was washed, leaving the immobilized receptor bound to the plate. The receptor was then interrogated using a europium-labeled antibody to the phosphotyrosine residue, and fluorescence was determined (method detailed in Fig. 2 ). Although this method had some drawbacks, including centrifugation of the plates prior to sample transfer, several features made it worthy of application for assaying the insulin receptor. Among the desirable features were that the assay was formatted for a 96-well plate, it measured phosphorylation directly, and the DELFIA system is a time-proven method amenable for high-throughput screening (HTS). Therefore, this method was optimized and used to implement a high-throughput insulin receptor kinase screen. This report discusses the modifications, as well as the issues, associated with the implementation of a cell-based assay to measure induction of receptor phosphorylation.
MATERIALS
Microtiter 96-well tissue culture plates were from BD Falcon (Becton Dickinson, Franklin Lakes, NJ). Black 96-well Maxisorp plates were from Nunc (Nalge-Nunc, Rochester, NY). Culture medium, serum, and insulin were from Invitrogen (Carlsbad, CA). Bovine serum albumin (BSA), Tris-HCl, Triton X-100, IGEPAL, deoxycholic acid, sodium vanadate, and sodium fluoride were from Sigma (St. Louis, MO). DELFIA assay reagents (assay buffer, wash buffer, enhancer solution, PT-66 phosphotyrosine antibody containing 8 europium molecules per antibody) were from PerkinElmer (Boston, MA). Insulin receptor antibody SC711 was from Santa Cruz (Santa Cruz, CA). Protease inhibitor cocktail (catalogue no. 1697498) and PeFaBloc SC were from Roche (Roche Diagnostics, Indianapolis, IN).
METHODS

Cell treatment
CHO-T cells were plated into 96-well plates in Hams F-12 Nutrient Mix containing 10% fetal bovine serum (FBS) and incubated for 48 h. The next day, the medium was removed and replaced with 100 µL of serum-free medium containing 0.1% BSA unless indicated otherwise. The cells were treated with compound or insulin (2.5 µL) for the times indicated at room temperature. In some experiments, 75 µL of medium was removed, and 100 µL of lysis buffer (1× contained 50 mM Tris-HCl, 1% Triton X-100, 1% IGEPAL, 0.25% deoxycholic acid, 150 mM NaCl, 1 tablet of protease inhibitor cocktail, PeFaBloc SC, 1 mM activated sodium orthovanadate, 8 and 1 mM sodium fluoride) was added to lyse the samples. In some experiments, cells were lysed by the addition of Cell-based receptor phosphorylation detected by DELFIA. In the assay, cells were stimulated with ligand and then lysed. Cell lysate was transferred to a plate precoated with antibody to the receptor. The sample was washed, and a europium-tagged antibody to the tyrosine was added and the resulting fluorescence detected. 50 µL of a 3× lysis buffer to the 102.5 µL of cells and medium. Samples were frozen at this point if necessary.
DELFIA assay Maxisorp plates were coated with 100 µL of insulin receptor antibody in Ca/Mg-free phosphate-buffered saline (PBS) in the indicated concentrations. The plates were incubated overnight at 4°C. The antibody solutions were removed and the wells washed twice with 150 µL of PBS. Then, 150 µL of blocking reagent (PBS with 1% BSA-fraction V) was added and the plates incubated for 1 h at room temperature. The solution was removed, and the plates were washed twice with 180 µL of PBS, leaving the wells empty. The cell lysates were triturated, and 80 µL of the cell lysates was immediately added to each well (80 µL was always used regardless of method of lysis). The samples were incubated for 1 h. The wells were washed 2 times with 200 µL of DELFIA wash buffer. Then, 100 µL of the europium-conjugated PT-66 phosphotyrosine antibody diluted in DELFIA assay buffer was added and the samples incubated 1 h. The wells were rinsed 3 times with 300 µL of the DELFIA wash buffer, and 150 µL of enhancer solution was added to the wells. The samples were incubated for 20 min and then read on the LJL Analyst in TRF mode with the following settings: 360 excitation, 620 emission, 410 dichroic. The machine was set to 100 readings/well, 10 msec/read, 1000-msec integration, and 50-msec delay after the flash.
RESULTS
Experiments were performed to establish the basic conditions necessary to run the assay. Given the variety of 96-well plate types available, it was important to establish which 96-well plate gave us the best signal to background. We required plates that would bind to the insulin receptor antibody with high affinity. Two basic plate types were tested: Nunc Maxisorp white and black. In this experiment, anti-insulin receptor antibody was coated onto the plate at 3 µg/mL. The PT-66 phosphotyrosine antibody was varied between 1 and 0.3 µg/mL. The results in Table 1 indicate that a PT-66 antibody concentration of 0.5 to 1 µg/mL produced a similar signal-tobackground ratio within a given plate type. Although the black plate had a lower total signal than the white plate, it had a greater signal-to-vehicle ratio due to the much lower background. Therefore, the Nunc Maxisorp black plate was used for all further studies.
Experiments were performed to optimize the concentration of capture antibody. In these experiments, cells were stimulated with either vehicle or 10 nM insulin. The capture antibody was varied from 0.25 to 3 µg/mL, with the PT-66 antiphosphotyrosine antibody kept constant at 0.7 µg/mL. The results in Figure 3 indicate that all concentrations of capture antibody tested gave an adequate signal-to-background ratio, with 3 µg/mL being maximal. A concentration of 0.5 µg/mL SC711 produced an optimal signal-tobackground ratio and was cost-effective for a HTS screen. Therefore, the concentration used for the remaining studies was 0.5 µg/ mL unless otherwise noted.
The concentration of PT-66 antibody to use in this system was tested. In these experiments, cells were stimulated with a dose titration of insulin, and the detection antibody was varied, with the capture antibody kept constant at 0.5 µg/mL. The experiment in Figure  4 indicates that there was a concentration-dependent increase in total signal with increasing detection antibody concentration. As expected, the increase in signal was closely correlated with the expected phosphorylation level of the receptor, regardless of the concentration of antibody. Treatment of CHO-T cells with insulin produced a concentration-dependent increase in receptor phosphorylation that was easily measured using the DELFIA system. The EC 50 for insulin-induced IR phosphorylation was 1.5 nM using 0.7 µg/mL of detection antibody. This value is similar to that reported by Biazzo-Ashnault et al. 6 when measuring insulin receptor activation indirectly via a FRET assay. All subsequent studies were done using 0.7 µg/mL of detection antibody. The results described above were obtained using cells that had been serum starved for 24 h prior to insulin induction. This was due to the expectation that endogenous growth factors present in the serum would contribute to a higher background. Because media replacement requires an additional step, we wanted to determine whether media replacement was necessary. Therefore, we tested the effect of serum starvation on the signal-to-noise ratio and on the EC 50 generated to insulin. In these experiments, cells were plated in medium containing 0.1% BSA or increasing amounts of FBS (1%-10%). Twenty-four hours prior to insulin stimulation, medium was removed from 1 set of samples plated in 10% serum and replaced with medium containing 0.1% BSA. The other samples were not disturbed. The samples were incubated for an additional 24 h, an insulin dose titration was performed, and receptor phosphorylation was measured. The data show that serum starvation had no effect on the background phosphorylation detected, the degree of insulin stimulation, or the EC 50 determined for insulin ( Table 2 ). In addition, the data obtained from samples plated in BSA looked identical to those plated in serum. Therefore, to eliminate another step in this assay, all future studies were performed using cells plated in medium containing serum, and the cells were not serum starved.
All experiments performed above were done with partial medium removal prior to the addition of lysis buffer. Medium removal can present several problems when attempting to automate an assay. These include a longer assay, additional steps on the automated system, and increased variability due to loss of cells via disruption of the cell monolayer. Therefore, studies were undertaken to determine whether cell lysis could be accomplished by the addition of lysis buffer directly to the cell/medium mixture. To directly compare the lysis conditions, cells were either lysed in 1× lysis buffer following the removal of media or lysed with 3× lysis buffer added directly to the cells in media. The results in Figure 5 show that the addition of 3× lysis buffer resulted in a larger signal than did the standard cell lysis, with no change in the EC 50 for insulin (data not shown). Therefore, the cells were lysed by addition of 3× lysis buffer without media removal.
Several features of this method needed to be tested to determine optimal operating conditions for implementation on an automated system. This included the establishment of upper and lower limits for insulin incubation times. Although all assays above were performed using a 10-min incubation, due to unpredicted events, a 10min incubation may not always be possible on the robot. Therefore, the effect of time on the insulin dose response was tested by adding insulin to the cells and incubating at room temperature for various periods of time prior to terminating the experiment. The times covered ranged from 5 to 120 min. These studies (Fig. 6 ) demonstrated that the degree of phosphorylation stimulated by the lower concentrations of insulin were identical for all times measured. After a 15-min incubation, the higher concentrations showed less phosphorylation. However, the lower phosphorylation at the longer incubation times did not significantly affect the assay in that the EC 50 s for insulin were relatively unchanged ( Table 3 ). Cells were plated into 96-well plates at 70K/well in medium containing 0.1% bovine serum albumin (BSA), 1% fetal bovine serum (FBS), 2.5% FBS, 5% FBS, and 10% FBS. Twentyfour hours later, the medium in half of the 10% FBS-containing plates was changed to medium without serum. The next day, the assay was performed as follows: 96-well plates were coated with 0.5 µg/mL of insulin receptor antibody (SC711) in phosphate-buffered saline (PBS) overnight. The plates were washed and blocked, as detailed in Methods. Medium on the cells was changed to medium with 0.1% BSA prior to the experiment. The cells were stimulated with a concentration curve to insulin for 10 min. Following stimulation, the cells were lysed using the 3× lysis method. The samples were incubated for 15 min at room temperature, triturated, and 80 µL transferred to the detection plate. The plates were incubated for 1 h at room temperature prior to washing. Phosphotyrosine was detected with 0.7 µg/mL PT-66 antibody, as detailed in Methods, and EC 50 s and maximum response were determined.
Insulin (nM)
This indicated that although it was optimal for the assay to be performed between 5 and 15 min, the assay was stable for up to 2 h. Another feature that needed to be tested for automation was the stability of insulin and cells at room temperature and room CO 2 . Insulin stability was tested by making an insulin dose titration and adding it to cells at 0 time through 120 min. The results in Figure 7 show that the dose titrations for insulin were identical from 0 time to 120 min, indicating that the insulin remained stable for at least 120 min. To test the stability of the cells at room temperature and room CO 2 , the cells were removed from the incubator and medium changed to serum-free medium containing 0.1% BSA and the cells incubated at room temperature and CO 2 . At various times, fresh insulin was added to the cells, which were incubated for 10 min prior to lysis buffer addition, and receptor phosphorylation was determined. The results in Figure 8 indicate that the cells were stable with room temperature/CO 2 incubation for at least 2 h throughout the dose range used. The assay was repeated to evaluate the Z′ fac- These data represent EC 50 s for insulin obtained from the data given in Figure 6 .
Insulin (nM) FIG. 7 . Stability of insulin at room temperature: 96-well plates were coated with 0.5µg/mL of insulin receptor antibody (SC711) in phosphatebuffered saline (PBS) overnight. The plates were washed and blocked, as detailed in Methods. An insulin dose-response curve was made at 0 time, and the curve was freshly tested or tested after incubation at room temperature for 60 and 120 min. The cells were freshly removed from the incubator at each time point. Following stimulation, the cells were lysed using the 3× lysis method. The samples were incubated for 15 min at room temperature, triturated, and 80 µL transferred to the detection plate. The plates were incubated for 1 h at room temperature prior to washing. Phosphotyrosine was detected with 0.7 µg/mL PT-66 antibody, as detailed in Methods. Each sample represents an average of triplicate samples ± the standard deviation.
tor performance in a manual mode. The Z′ factor plate shown in Figure 9 was acceptable for automation. The assay was formatted on the Allegro UHTS system, as shown in Table 4 , and run in a module validation format. That is, the assay was run using the Allegro modules as stand-alone units prior to the robotic implementation. The Z′ factor plate from this assay showed an unacceptable Z′ of 0.26 (Fig. 10) . A manual plate was run in parallel and exhibited the same Z′. The failure of this assay was evaluated. There was only 1 item different between this robotic assay and the previous manual assays: the Nunc antibodycoated plates were blocked and washed and let dry prior to the assay, whereas all previous assays were performed by addition of lysate to a freshly blocked, washed, and wet plate. To test this hypothesis, parallel plates were coated and blocked. One was washed and air-dried; the other was kept hydrated with PBS removed prior to lysate addition. Z factor analyses were performed on these 2 plates. The results showed that the hydrated plate exhibited superior performance. (Z′ hydrated = > 0.5, Z′ of dried plate < 0 ).
Because of the difficulty in producing a functional antibodycoated dry plate in-house, the decision was made to outsource the antibody plate production to Pierce (Rockford, IL). The conditions chosen were 0.5 µg/mL of SC711 antibody to coat the plates and E Block to block. The advantages of these plates were that they were dry and came from a single lot. The Z′ factor of these plates using a homogeneous lysate pool was Z′ = 0.65. These plates were used in robotic implementation of the assay. The assay was validated again on the Allegro UHTS with mixed results. In these runs, the Z′ factor was adequate for screening (Z′ = 0.55) some of the time, but 1  2  3  4  5  6  7  8  9  10  11  12 Avg stdev cv  Vehicle   271  289  285  301  244  266  345  284  352  291  272  469  306  57  19  258  269  275  206  233  265  262  315  266  219  253  263  257  27  10  241  283  274  261  231  216  229  239  242  248  252  229  245  19  8  235  255  228  245  252  252  255  237  253  278  234  267  249  14  6   Ligand   4584  4724  4385  5483  4944  5863  5318  5053  5460  6231  6427  5151  5302  606  11  3950  4948  5456  5552  5389  5335  6458  6856  4814  5335  4463  5070  5302  753  14  4401  5098  3840  6152  6107  6356  6443  5963  5250  5789  4867  4373  5387  838  16  5377  4761  4960  6204  6021  6771  7347  6361  6184  6266  5561  4790  5884  774 FIG. 9. Z′ factor plate performed manually: 96-well Maxisorp plates were coated with 0.5 µg/mL of insulin receptor antibody (SC711) in phosphatebuffered saline (PBS) overnight. The plates were washed and blocked, as detailed in Methods. Insulin at 10 nM (final concentration) or vehicle was added to 48 wells each. The cells were incubated for 10 min and lysed using the 3× lysis method. The samples were incubated for 15 min at room temperature, triturated, and 80 µL transferred to the detection plate. The plates were incubated for 1 h at room temperature prior to washing. Phosphotyrosine was detected with 0.7 µg/mL PT-66 antibody, as detailed in Methods. The Z′ factor was calculated to be equal to 0.52. more often than not, the Z′ failed to reach that level, resulting in the ultimate removal of the assay from the ultra-HTS (uHTS) queue.
DISCUSSION
Like other receptor tyrosine kinases, autophosphorylation of the insulin receptor activates the intrinsic tyrosine kinase activity.
Until recently, this class of targets had to be assayed by measuring kinase activity of the partially purified receptor or receptor phosphorylation using Western blot technology. This gap led to limitations in the ability to directly screen for receptor modulators. DELFIA technology is an invaluable tool for this sensitive measurement. It has required characteristics such as low endogenous background and large specific signal. Using the DELFIA assay, we were able to format an insulin receptor phosphorylation assay into a 96-well plate. The assay was modified from the trkA assay of Angeles et al. 7 by eliminating the need to remove medium prior to lysis and eliminating the centrifugation step after lysing the cells. We did find that the addition of the 3× lysis solution resulted in a greater signal than that found with the 1× solution. This can be partially explained by calculating the final concentration of lysis solution in those wells. In the 1× case, the assay was performed by the removal of all but 35 µL of medium prior to an addition of a 1× reagent. This resulted in a final concentration of 75% of the original lysis buffer. With the 3× solution, the final concentration was 97% of the original lysis buffer; hence, the increased activity may reflect better solubilization of the receptor due to the higher final concentration of lysis reagents in the mix.
The assay was validated manually and with automation. During the initial robotic validation, we found that coating plates with antibody in-house resulted in problems in the assay when trying to automate. These problems included increased variability when the FIG. 10. Z′ factor plate performed robotically: 96-well Maxisorp plates were coated with 0.5 µg/mL of insulin receptor antibody (SC711) in phosphatebuffered saline (PBS) overnight. The plates were washed and blocked, as detailed in Methods, and loaded dry onto the Allegro UHTS system. The assay was performed in a module validation mode using the modules detailed in Table 4 . Insulin at 10 nM (final concentration) or vehicle was added to 48 wells each. The cells were incubated for 10 min and lysed using the 3× lysis method. The samples were incubated for 15 min at room temperature, triturated, and 80 µL transferred to the detection plate. The plates were incubated for 1 h at room temperature prior to washing. Phosphotyrosine was detected with 0.7 µg/ mL PT-66 antibody, as detailed in Methods. The Z′ factor was calculated to be equal to 0.26. Step Module plates became dry and the large time commitment for dedicated personnel for plate coating. A viable solution was to outsource the coating of the plates. This solution provided several advantages:
(1) plates come from a single lot, thus providing greater consistency; (2) dry plates exhibited a decrease in variability; and (3) personnel resources were minimized. However, when trying to automate the assay to a uHTS level even with these plates, although a Z′ of 0.55 could be reached, the assay failed to routinely achieve adequate Z′ factors. The robotic situation was completely unlike the situation achieved with walk-up stations or manually when adequate Z factors were routinely obtained. What was the reason for the discrepancy between these assay formats? The most likely reason is due to the nature of both assay types. In uHTS, reagents and cells are placed on a platform with automation equipment, and the assay is performed from beginning to end with minimal personnel involvement at each step. Only major problems are typically observed, such as tip crashes, washers running out of fluid, and so forth. In a walk-up workstation environment, the operator is personally involved at every step of the assay. The operator can observe if there are issues with pipettes or washers and can take corrective measures to immediately solve the problem. In an assay such as this one, a workstation approach is a more viable alternative, although the throughput is compromised.
